Abstract
Dopamine D3 receptors have been implicated as potential pharmacotherapeutic targets for cocaine addiction because of their restricted localization to limbic brain regions and involvement in the behavioral effects of cocaine (Heidbreder and Newman, 2010). The rationale for developing D3 receptor-selective treatment candidates has been strengthened by evidence suggesting a history of cocaine use dynamically impacts D3 receptor expression and activity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
